Literature DB >> 11239613

Menstruation: choosing whether...and when.

A M Kaunitz1.   

Abstract

For many women in the United States, menstruation is a major health concern because menstrual disorders and other conditions that may be aggravated during menses (e.g., migraine headaches, epilepsy) carry substantial morbidity. Women today menstruate nearly 3 times as often as in primitive societies, and evidence suggests that frequent, repetitive menstrual cycles may increase health risks. Because the conventional 21/7 combination oral contraceptive (OC) regimen provides only limited relief for women with menstrual disorders, alternative OC regimens that reduce menstrual frequency have been proposed. A new OC formulation specifically designed to decrease menstrual bleeding to 4 times per year is currently under investigation. Most women welcome less frequent menses or even amenorrhea. Women who may derive particular benefit from reduced menstrual frequency include not only those with medical conditions directly caused or aggravated by menses, but also those serving in the military, female athletes, mentally-retarded women with menstrual hygiene problems, young teens, and perimenopausal women.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11239613     DOI: 10.1016/s0010-7824(00)00182-7

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  10 in total

Review 1.  Noncontraceptive health benefits of oral contraceptives.

Authors:  Andrew M Kaunitz
Journal:  Rev Endocr Metab Disord       Date:  2002-09       Impact factor: 6.514

2.  Continuous compared with cyclic oral contraceptives for the treatment of primary dysmenorrhea: a randomized controlled trial.

Authors:  Romana Dmitrovic; Allen R Kunselman; Richard S Legro
Journal:  Obstet Gynecol       Date:  2012-06       Impact factor: 7.661

Review 3.  The use of triptans in the management of menstrual migraine.

Authors:  Lisa K Mannix; Julia A Files
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 4.  Hormonal Contraception and Depression: Updated Evidence and Implications in Clinical Practice.

Authors:  Franca Fruzzetti; Tiziana Fidecicchi
Journal:  Clin Drug Investig       Date:  2020-12       Impact factor: 2.859

Review 5.  Hormonal contraception in adolescents: special considerations.

Authors:  Rollyn M Ornstein; Martin M Fisher
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

6.  Safety, efficacy and patient satisfaction with continuous daily administration of levonorgestrel/ethinylestradiol oral contraceptives.

Authors:  Giuseppe Benagiano; Sabina Carrara; Valentina Filippi
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

7.  Offering extended use of the combined contraceptive pill: a survey of specialist family planning services.

Authors:  Ulrike Sauer; Sue Mann; Nataliya Brima; Judith Stephenson
Journal:  Int J Womens Health       Date:  2013-09-30

Review 8.  Menstrual suppression: current perspectives.

Authors:  Paula Adams Hillard
Journal:  Int J Womens Health       Date:  2014-06-23

Review 9.  Extended regimen combined oral contraception: A review of evolving concepts and acceptance by women and clinicians.

Authors:  Rossella E Nappi; Andrew M Kaunitz; Johannes Bitzer
Journal:  Eur J Contracept Reprod Health Care       Date:  2015-11-17       Impact factor: 1.848

10.  The myth of menstruation: how menstrual regulation and suppression impact contraceptive choice.

Authors:  Andrea L DeMaria; Beth Sundstrom; Stephanie Meier; Abigail Wiseley
Journal:  BMC Womens Health       Date:  2019-10-28       Impact factor: 2.809

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.